ResearcherActive in the last 2 years
Liang Zhou
Matched on ORCID iD 0009-0003-9118-5492; OpenAlex author ID A5035218225. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2014: 2 papers · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper
Papers 4
- 5HT2A modulation attenuates pancreatic cancer induced pain mouse model by inhibiting HDAC. Co-author DOI 10.1590/acb392324↗
- Association between high levels of Notch3 expression and high invasion and poor overall survival rates in pancreatic ductal adenocarcinoma. First author DOI 10.3892/or.2016.5079↗
- MicroRNA-183 is involved in cell proliferation, survival and poor prognosis in pancreatic ductal adenocarcinoma by regulating Bmi-1. Co-author DOI 10.3892/or.2014.3374↗
- MicroRNA-135a inhibits cell proliferation by targeting Bmi1 in pancreatic ductal adenocarcinoma. Co-author DOI 10.7150/ijbs.8097↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Alok Shiomurti Tripathi · 1 shared paper, 2024 · strength 0.26
- Weiwei Fan · 1 shared paper, 2024 · strength 0.26
- Yanling Yang · 1 shared paper, 2016 · strength 0.06
- Jinxue Zhou · 1 shared paper, 2016 · strength 0.06
- Desheng Wang · 1 shared paper, 2014 · strength 0.05
- Kaishan Tao · 1 shared paper, 2014 · strength 0.05
- Dou Ke-feng · 1 shared paper, 2014 · strength 0.05
- Zheng Dang · 1 shared paper, 2014 · strength 0.04
- Kefeng Dou · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.